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ABSTRACT
Aims Pharmacogenetic smoking cessation interventions would involve smokers being given information about the
inﬂuence of genes on their behaviour. However, attributing smoking to genetic causes may reduce perceived control
over smoking, reducing quit attempt success. This study examines whether attributing smoking to genetic inﬂu-
ences is associated with reduced quitting and whether this effect is mediated by perceived control over smoking.
Design Cohort study. Participants A total of 792 smokers, participating in a trial of nicotine replacement therapy
(NRT)-assisted smoking cessation. Participants were informed that the trial investigated relationships between genetic
markersandsmokingbehaviour,butpersonalizedgeneticfeedbackwasnotprovided.Setting PrimarycareinOxford-
shireandBuckinghamshire,UK.Measurements Perceivedcontroloversmokingandperceivedimportanceof genetic
factors in causing smoking assessed pre-quit; abstinence 4, 12, 26 and 52 weeks after the start of treatment.
Findings A total of 515 smokers (65.0%) viewed genetic factors as playing some role in causing their smoking.They
had lower perceived control over smoking than smokers who viewed genetic factors as having no role in causing their
smoking. Attributing smoking to genetic causes was not associated signiﬁcantly with a lower probability of quit
attempt success. Conclusions Attributing smoking to genetic factors was associated with lower levels of perceived
control over smoking but not lower quit rates. This suggests that learning of one’s genetic predisposition to smoking
duringapharmacogeneticallytailoredsmokingcessationinterventionmaynotdeterquitting.Furtherresearchshould
examine whether the lack of impact of genetic attributions on quit attempt success is also found in smokers provided
with personalized genetic feedback.
Keywords Behavioural inﬂuences, causal attributions, genetic testing, perceived control, pharmacogenetic inter-
vention, smoking cessation.
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INTRODUCTION
Preliminary evidence suggests that effectiveness of
medication for smoking cessation may be moderated
by genotype [1–3]. For example, smokers with the
Asp40 variant of the mu-opioid receptor gene had
double the quit rate with higher-dose nicotine replace-
ment therapy (NRT) than with lower-dose NRT, while
smokers homozygous for the more common Asn40
variant were equally likely to stop smoking regardless
of NRT level [1]. Therefore, genetic testing might allow
tailoring of smoking cessation therapies to maximize
smokers’ likelihood of quitting successfully [4]. Realizing
this potential will necessitate providing smokers with
information about how genetic factors contribute to
their smoking. The psychological impact of providing
such information requires consideration.
Leventhal’s Self Regulation Model (SRM) suggests
that individuals’ perceptions of a health problem, includ-
ing its causes, inﬂuence their perceived control over the
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conditions with genetic causes are viewed as less control-
lable than those with behavioural or environmental
causes [7]. Therefore, informing smokers that their
smoking is caused partly by genetic factors may lead
them to believe they have less control over their behav-
iour than were they not given this information. High per-
ceived control is associated with successful recovery from
addiction [8,9], so providing smokers with information
about their genotype to explain the choice of cessation
therapycouldreduceperceivedcontrolandtherebyaffect
adversely quit attempt success.
The SRM also suggests that changing causal beliefs
about smoking by providing genetic information will
inﬂuence perceptions about effective action to control the
healthcondition.Whenhealthproblemsareattributedto
genes, pharmacological treatments are seen as more
effective [10,11] than when they are attributed to non-
genetic factors. This could lead smokers who attribute
their smoking to genetic causes to view nicotine replace-
ment therapy (NRT) as an appropriate treatment, a view
that may in turn increase their perceived control over
stopping smoking, so countering the effect of making a
genetic causal attribution.
To date, one study has examined smokers’ reactions
to learning of a genetic predisposition to nicotine depen-
dence, using analogue methods [12]. Smokers read
vignettes in which they were asked to imagine that they
did (gene positive condition) or did not (gene negative
condition) have a gene that made them more likely to be
addicted to nicotine. Smokers in the gene-positive group
were signiﬁcantly less likely than those in the gene-
negative group to say they would use willpower but
more likely to say they would use bupropion to quit, as
predicted by SRM. This unwillingness to use willpower
might imply a reduced sense of control over smoking.
However, the gene-positive and gene-negative groups
had similar scores on a scale assessing perceived control,
which does not accord with SRM predictions. That study
was a simulation and did not focus on smokers ready
to quit. In this report, we examine the effects of attri-
buting one’s smoking to genetic causal factors in real
quitters.
Hypotheses
This study tests three hypotheses in a cohort of smokers
making an NRT-assisted quit attempt:
1 Smokers who view genetic factors as playing a role in
causing their smoking have lower perceived control
over their smoking than those who do not.
2 Smokers who view genetic factors as playing a role
in causing their smoking are less likely to quit
successfully.
3 The effect of viewing genetic factors as causing one’s
smoking on quitting will be mediated by perceived
control over smoking (as shown in Fig. 1).
METHODS
Study design
The current study involved individuals participating in
the Patch in Practice (PIP) randomized controlled trial of
the effects of providing moderate or low levels of support
to smokers making an NRT-assisted cessation attempt
(ISRCTN05689186) [13].
Sample
Participants were eligible if they were aged 18 years and
over and smoked 10 cigarettes per day or more. Partici-
pants were recruited from 26 general practices in Buck-
inghamshire and Oxfordshire. General practitioners
(GPs) recruited patients attending for other reasons
(n = 60, 6.5%), or patients volunteered having seen
posters or heard about the study (n = 15, 1.6%). In some
practices we wrote to every registered smoker, offering
trial entry (n = 850, 91.9%).
Importantly, from the perspective of understanding
the impact of beliefs in genetic causes of smoking on
perceived control and quitting, the invitation letter
described the aims of the study as being ‘to see if consti-
tutional genetic factors affect the ability of smokers like
yourself to give up using nicotine patches; to see how
muchnicotinereplacementhelpssmokerstogiveup;and
how much support from the surgery helps’.The informa-
tionsheetforthetrialalsoexplainedthatthestudywould
explore the role of genetic factors in smoking behaviour,
stating:‘Wewanttotestatheorythatcommonvariations
in smokers’ genes make a difference to how successful
they are at using NRT’.
Potential participants were excluded only if they had
contraindications to nicotine replacement therapy. Once
consent was given, all participants set a quit day. Nurses
encouraged participants to quit within 3–4 days of the
ﬁrst visit (NV1) and arranged a further visit 1 week later
(NV2). At NV1, all participants were given a 15-mg nico-
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Figure 1 Proposed model of how the impact of viewing smoking as
having a genetic cause may reduce quit attempt success
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dispensed in two packs 4 weeks apart, and completed a
questionnaire.
Participants in the moderate support group had three
additional contacts: a telephone call about 1 week after
quit day, a nurse visit 10 days after the quit day and a
third telephone call 3 weeks after NV1. All participants
were scheduled for a nurse visit 4 weeks after NV1. Par-
ticipantswereaskedtocompleteaquestionnairecontain-
ing the psychological measures reported in this paper at
NV1, and 881 of the 925 (95.2%) did so.
Measures
Psychological variables
Perceived control over smoking was assessed using
Velicer et al.’s nine-item self-efﬁcacy for coping with
tempting situations scale [14] (a=0.84). This scale
assesses smokers’ perceptions of their ability to control
their smoking in nine situations (e.g. ‘when I ﬁrst get up
in the morning’, ‘with friends at a party’) and so, despite
its title, this scale can be considered to measure perceived
control.
Attributing one’s smoking to genetic causes was
assessed using four items, developed for this study, as no
suitable measures existed. Because pilot work found that
smokers attributed smoking initiation to different factors
than those they felt were important causes of their
current smoking, the items were introduced by the state-
ment: ‘People have different ideas about the reasons why
they started smoking and the reasons why they smoke
now. How important do you think the following are as
causes of your smoking now?’. The four items were ‘A
genetic vulnerability to nicotine addiction runs in my
family’, ‘Being addicted to smoking is in my genes’, ‘I
inherited a tendency to be addicted to smoking’ and
‘Addiction to nicotine runs in my family’. All items were
rated on a seven-point scale with end-points of [1] ‘not
an important cause’ to [7] ‘a very important cause’,
a=0.90. The items were interspersed with ﬁller items
about attributing smoking to other causes, such as stress
and habit, results for which are not reported. Of the par-
ticipants, 792 (85.6%) completed all four items. All sub-
sequent data are derived from this subgroup of the trial
participants.
Smoking behaviour variables
Participants’ level of nicotine dependence was assessed
using the Fagerström Test for Nicotine Dependence
(FTND) [15]. On average, participants were moderately
dependent on nicotine, with a mean (SE) FTND score of
5.1 (2.2). They also recorded the length of their longest
previous quit attempt. The median (interquartile range)
for this variable was 24 (177) days.
Ateachnursevisit,participants’exhaledcarbonmon-
oxide (CO) was measured and participants were asked
whether they had smoked since the last visit and smoked
during the past 7 days. Participants were telephoned at
12 weeks, 6 months and 1 year from the quit day to
assess smoking status, with participants reporting absti-
nence sending salivary cotinine samples by post for bio-
chemical validation.The smoking status variable used in
this study was conﬁrmed sustained abstinence. This was
deﬁned as reporting no cigarettes from NV2 (providing
NV2 was undertaken 14 days or fewer from quit day) to
the index time, with exhaled CO less than 10 parts per
million, or salivary cotinine concentration less than
15 ng/ml on each occasion [16].
Participant demographics
The mean (SD) age of the participants was 43.6 (12.3)
years.
Statistical analysis
Path analysis, using Mplus [17], was used to examine
whether the effect of attributing smoking to genetic
causes on quitting was mediated by perceived control. In
these analyses, we also controlled for the effects of nico-
tine dependence, longest previous quit attempt and trial
arm (support level), as these may all be related to per-
ceived control and quit attempt success. There was no
evidence of multi-collinearity.
RESULTS
The mean (SD) score on the genetic causes scale was 2.6
(1.8). However, scores on this scale were highly skewed:
277 (35.0%) participants had the lowest possible score
(i.e. they responded ‘not at all an important cause’ in
response to all four genetic causal attribution items).
Therefore, we dichotomized this scale and used the new
variable, genes viewed as possibly important in causing
smoking(yesorno),inallfurtheranalyses.Differencesin
smoking behaviour and demographic variables between
participants who viewed genes as possibly important in
causing their smoking and those who did not are shown
in Table 1.
The ﬁrst hypothesis was that smokers who viewed
genetic factors as playing a role in causing their smoking
would have lower perceived control over their smoking
thanthosewhodidnot.Participantswhoviewedgenesas
a possible cause of their smoking reported signiﬁcantly
lower perceived control over smoking [mean (SD) = 2.59
(0.67)] than those who did not [mean (SD) = 2.76
(0.68)]. This difference was signiﬁcant, controlling for
FTND and length of previous quit attempt, F1,737 = 6.91,
P = 0.009.
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genetic factors as playing a role in causing their con-
tinued smoking would be less likely to quit. People
who viewed genes as important were less likely to quit at
all time-points, but the effects were small and were not
statistically signiﬁcant (Table 2).
Finally, we predicted that any effect or quitting of per-
ceiving genes as possibly important in causing smoking
on quitting would be mediated by perceived control. The
coefﬁcients for the relevant path analyses are shown in
Table 3. If perceived control mediated the effect of per-
ceiving genes as important, then adding it to the model
(ﬁnal two columns of Table 3) should markedly reduce
the association between perceiving genes as important
and cessation. However, the size of the path between per-
ceiving genes as important and quitting is barely dimin-
ished by including perceived control in the model. This
was conﬁrmed by the formal test of mediation. Neither
the total, nor the indirect, effects of viewing genes as a
cause of smoking on quitting were signiﬁcant at any
time-point.Wecanthereforeconcludethatalthoughper-
ceiving genes as a possible cause of smoking decreased
perceived control, it had no effect on quitting. Therefore,
the third hypothesis was not conﬁrmed.
DISCUSSION
As predicted, smokers who viewed genes as a possible
cause of their smoking perceived lower control over their
smoking. However, contrary to the second hypothesis,
these participants were not signiﬁcantly less likely to quit
successfully. The ﬁnal hypothesis of this study was that
the lower quit attempt success experienced by smokers
who perceived genes to be a possible cause of their
smokingwouldbemediatedbythesesmokersfeelingthat
they had less control over their smoking. However, given
thatsmokerswhoperceivedgenestobeapossiblecauseof
their smoking did not have lower quit attempt success,
it is not surprising that such mediation was not
demonstrated.
Previous research suggested that attributing a condi-
tion to genetic causes would be associated with lower
perceived control over the condition [7]. We replicated
this in the context of smoking behaviour. This ﬁnding
Table 1 Differences on demographic and smoking behaviour variables between participants who did and did not view genes as
possibly important in causing their smoking.
Variable
Role of genes in
causing smoking? Mean SD t d.f. P
FTND Possibly important 5.3 2.1 -4.43 776 <0.001
Not at all important 4.6 2.2
Longest previous quit
attempt (days)
Possibly important 220 628 0.27 779 0.79
Not at all important 232 498
Age (years) Possibly important 45 12.1 -3.43 787 0.001
Not at all important 42 11.9
% female n female c
2 d.f. P
Gender Possibly important 51.7 266 0.044 1 0.82
Not at all important 52.7 146
FTND: Fagerström Test for Nicotine Dependence.
Table 2 Quit rates according to whether participants perceived genes as a possible cause of their smoking.
Time
point
Genes not
important,
n = 277
Genes possibly
important,
n = 515 Unadjusted odds ratio (95% CI)
for the effect of perceiving genes
as possibly important on quitting
Adjusted odds ratio (95% CI)
for the effect of perceiving genes
as possibly important on quitting* %q u i t n %q u i t n
1 week 39.0 108 37.5 193 0.94 (0.70–1.27) 0.95 (0.64–1.30)
4 weeks 25.6 71 22.1 114 0.83 (0.59–1.16) 0.85 (0.60–1.21)
12 weeks 16.6 46 12.8 66 0.74 (0.50–1.11) 0.72 (0.47–1.10)
26 weeks 13.4 37 9.3 48 0.67 (0.42–1.05) 0.67 (0.41–1.07)
52 weeks 10.1 28 6.6 34 0.63 (0.37–1.06) 0.61 (0.35–1.05)
*Controlling for nicotine dependence (FTND), longest previous quit attempt and trial arm.
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inperceivedcontroloversmokingbetweensmokersasked
toimaginetheydidordidnotreceiveapositiveresultof a
genetic test for vulnerability to nicotine dependence.
However, the effect size in this study was similar
(d = 0.25, 95% CI 0.10–0.40) to that in the Wright et al.
study(d = 0.33,95%CI-0.01–0.67),sothemainreason
for this is probably that the Wright et al. study lacked
power to observe this relatively small effect. Given the
magnitude of the effect, the difference in perceived
control may not be clinically signiﬁcant.
Finally, the present study examined the effect of
genetic causal attributions on behaviour, but did not
ﬁnd that people who viewed their smoking as possibly
caused by genes were less likely to quit successfully. Per-
ceived control did not predict quitting in this study,
whereas results of other studies reported this associa-
tion [8]. There are several possible reasons for this dis-
crepancy. First, in the current study all participants
received NRT and support from their practice nurse.
These may have helped participants to overcome their
lack of perceived control and quit successfully. Perceived
control may predict quitting more strongly when phar-
macotherapy is not made available. Secondly, some evi-
dence suggests that very high levels of self-efﬁcacy for
quitting, a construct closely related to perceived control,
may have a detrimental effect on quit attempt success.
Such quitters might neglect to use of coping skills and
put themselves in high-risk situations [18]. For this sub-
group of smokers there would be a negative association
between perceived control and quit attempt success,
while for other, less conﬁdent smokers, the association
would be positive. Combining those two groups may lead
to the two contrasting associations cancelling each
other out, resulting in no signiﬁcant observed associa-
tion between perceived control and quit attempt success.
However, we tested for this and found no evidence in
support of a negative association between perceived
control and quitting in smokers with the highest levels
of perceived control. Thirdly, although some studies
have shown associations between the perceived control
over smoking and quitting [19,20], these studies did not
use biochemical validation of smoking status, unlike the
present study. This may have caused biased estimates of
the relationship between scores on this scale and quit
rates. Individuals with higher scores might have been
more likely to report that they were non-smokers
because their greater perceived control led to their per-
ceiving any lapses as temporary, thus reporting them-
selves to be non-smokers. Finally, there may be speciﬁc
psychometric issues with the particular scale used in
this study. Another study using the same instrument
also found no association between perceived control and
quitting [21].
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Contrary to prediction, there was no association between
smokersviewinggenesasapossiblecauseof theirbehav-
iour and a reduced likelihood of smoking cessation. One
explanation for this is that attributing smoking to genetic
causesdoesnotinﬂuencequitattemptsuccess.Inastudy
of individuals with familial hypercholesterolaemia, those
who received mutation-positive results of genetic testing
were just as likely to perform risk-reducing behaviours as
individuals who received mutation-negative results or
who were not offered testing [11]. Therefore, contrary to
speculation, making genetic attributions may not cause
fatalism and deter behaviour change.
Secondly,thereasonsforwhichsmokersinthepresent
study attributed their smoking to genetic causes are
unknown. Smokers who believed genes were a possible
cause of their smoking may not have had genotypes that
predisposed them to difﬁculties quitting, and so quit suc-
cessfully. Alternatively, if smokers’ attributions to genetic
causes do reﬂect accurately the genetic inﬂuence on their
smoking behaviour, then controlling for nicotine depen-
dency (which somewhat reﬂects the individual’s geno-
type) may have attenuated the relationship between
attributions to genetic causes and quit attempt success.
However, FTND score was only associated signiﬁcantly
with quit attempt success at 1 and 4 weeks of follow-up,
and the associated odds ratios were relatively small.
Recent formulations of the Self-Regulation Model [6]
suggestthatitwouldhavebeenusefultomeasurepercep-
tions of treatment control—the belief that medications
or health professionals can successfully control a health
condition—in addition to perceived personal control over
smoking. The lower perceived personal control reported
by smokers who attributed their smoking to genetic
causes might be merely a corollary to their having
increasedperceptionsof treatmentcontrol.Smokerswho
thought genes were a possible cause of their smoking
may have felt that NRT was more appropriate than will-
power for helping them stop smoking [12]. Therefore,
smokers in the present study might have thought their
use of NRT was an important factor in controlling the
successof theircessationattemptandsowereabletoquit
successfully while using nicotine replacement products.
In terms of whether pharmacogenetic smoking cessa-
tion strategies are likely to be effective, this study’s results
suggest that viewing genes as a cause of one’s smoking is
not necessarily a barrier to successful quitting. However,
itisimportanttorememberthatparticipantsinthisstudy
were not given personalized information about the role of
geneticfactorsintheirsmoking.Whethertheprovisionof
personalized genetic feedback leads to fatalism, and so
reduced quit-attempt success, remains unknown. Per-
sonalized genetic feedback may not have the detrimental
effectsonbehaviourchange.Insteadof perceivingdimin-
ished control over the problem, individuals may instead
make extra efforts to control it through risk-reducing
behaviour. In support of this, a study of individuals given
either a genetic or a non-genetic diagnosis of familial
hypercholesterolaemia showed that genetic feedback did
not reduce perceived control over the condition or over
risk-reducing behaviour [11].
Strengths, limitations and suggestions for further
research
Thisistheﬁrststudytoexaminetherelationshipbetween
attributing smoking to genetic causes and biochemically
validated abstinence. It is also the ﬁrst study to examine
the relationship between viewing genes as a cause of
smoking and perceived control over smoking in a group
of smokers who are ready to quit. It can inform studies of
the impact of providing smokers with pharmacogeneti-
callytailoredsmokingcessationinterventions.Thisstudy
beneﬁts from using a large sample of smokers recruited
from primary care who are likely to be representative of
British smokers who might volunteer for trials of phar-
macogenetic treatment strategies. However, the partici-
pants are not representative of the general population of
British smokers, as treatment services see more depen-
dent smokers. Also, the recruitment materials mentioned
that one of the study’s aims was to examine if genetic
factors affect smokers’ ability to quit using nicotine
patches, which may have resulted in the preferential
recruitment of smokers concerned about genetic causes
of their smoking behaviour. However, these are exactly
the smokers we might expect to respond to invitations for
pharmacogenetic cessation interventions.
The present study has some limitations. It is not pos-
sible to establish the causal direction of the links between
perceivinggenesasapossiblecauseof one’ssmokingand
perceived control, as both were measured concurrently
and neither was manipulated experimentally. It would
also be informative to explore smokers’ beliefs about
genetic inﬂuences on smoking and smoking cessation
more fully. For example, do smokers who believe that
genetic factors inﬂuence their smoking also believe that
they will therefore have greater than average difﬁculty in
changing their behaviour? Are smokers who believe
genes inﬂuence their smoking more likely to view phar-
macological cessation therapies as effective? Randomized
trials of the effects of providing pharmacogenetic feed-
back during smoking cessation attempts including more
complete measurement of smokers’ beliefs regarding the
inﬂuence of genetic factors of quitting, such as the
recently initiated Genetic Risk and Behaviour change
(GRaB) trial (ISRCTN14352545), are needed. Future
research could also examine how well smokers’ beliefs
1662 Alison J. Wright et al.
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are related to their actual genotype. Individuals with
strong prior beliefs that genetic factors affect their
smoking may increase their self-efﬁcacy for quitting if
genetic testing shows that this is not the case. Alterna-
tively,if thisisshowntobethecaseandtheirprescription
for cessation aids is tailored accordingly, their perceived
control may increase. It is also possible that some
smokers, even if they do have a ‘risky’ genotype, overes-
timate the importance of genetic factors in smoking and
in their ability to quit. Such smokers may beneﬁt from
education about the multi-factorial inﬂuences on
smoking and smoking cessation.
CONCLUSIONS
Currently, little is known about the potential psychologi-
cal impact of providing genetic risk information to
smokers as part of pharmacogenetic smoking cessation
strategies. This study found that perceiving genes as an
inﬂuence on smoking was associated with slightly lower
perceptions of control over smoking, but not with a
reducedlikelihoodof stoppingsmoking.Furtherresearch
should examine whether the lack of impact of genetic
attributions on quit attempt success is also found in
smokers provided with personalized genetic feedback
as part of the pharmacogenetic tailoring of smoking
cessation therapies.
Acknowledgements
The randomized controlled trial from which participants
were drawn was funded by Cancer Research UK, a
medical research charity (ref. C53/A6281). The ﬁrst
authoriscurrentlysupportedbyaResearchTrainingFel-
lowship in Health Service Research (ref 062183/Z/00/Z)
from the WellcomeTrust, a medical research charity.The
second author is supported by a National Institute of
HealthResearchCareerScientistAward.UnitedPharma-
ceuticals supplied the nicotine patches for the study free
to be given without charge to the participants. We would
liketothankthegeneralpractitionersandpracticenurses
who recruited participants, as well as the other members
of the General Practice Research Group at the University
of Oxford who contributed to the design and running of
the Patch in Practice trial.
Declaration of interest
MikeMurphyhasIntellectualPropertyinterestsonly(not
ﬁnancial) in the company G-Nostics Ltd, which is
concerned with exploiting the application of molecular
biological diagnostics to smoking cessation. He also
received fees for scientiﬁc consultancy services through
University of Oxford ISIS Innovation to G-Nostics Ltd for
3 months to November 2004.
References
1. Lerman C., Wileyto E. P., Patterson F., Rukstalis M.,
Audrain-McGovern J., Restine S. et al. The functional mu
opioid receptor (OPRM1) Asn40Asp variant predicts short-
term response to nicotine replacement therapy in a clinical
trial. Pharmacogenomics J 2004; 4: 184–92.
2. Lerman C., Jepson C., Wileyto E. P., Epstein L. H., Rukstalis
M., Patterson F. et al. Role of functional genetic variation in
the dopamine D2 receptor (DRD2) in response to bupropion
and nicotine replacement therapy for tobacco dependence:
results of two randomized clinical trials 10.1038/
sj.npp.1300861.Neuropsychopharmacology2006;31:231–
42.
3. Swan G. E., Valdes A. M., Ring H. Z., Khroyan T. V., Jack L.
M., Ton C. C. et al. Dopamine receptor DRD2 genotype and
smoking cessation outcome following treatment with
bupropion SR. Pharmacogenomics J 2005; 5: 21–9.
4. Munafo M. R., Shields A. E., Berrettini W., Patterson F.,
Lerman C. Pharmacogenetics and nicotine addiction
treatment. Pharmacogenomics 2005; 6: 211–23.
5. LeventhalH.,LeventhalE.A.,ContradaR.J.Self-regulation,
health and behaviour: a perceptual-cognitive approach.
Psychol Health 1998; 13: 717–33.
6. Marteau T. M., Weinman J. Self-regulation and the behav-
ioural response to DNA risk information: a theoretical
analysis and framework for future research. Soc Sci Med
2006; 62: 1360–8.
7. ShilohS.,Rashuk-RosenthalD.,BenyaminiY.Illnesscausal
attributions. An exploratory study of their structure and
associationswithotherillnesscognitionsandperceptionsof
control. J Behav Med 2002; 25: 373–94.
8. Godin G., Kok G. The theory of planned behavior: a review
of its applications to health-related behaviors. Am J Health
Promot 1996; 11: 87–98.
9. ConnerM.,NormanP.PredictingHealthBehaviour,2ndedn.
Maidenhead: Open University Press; 2005.
10. Phelan J. C., Yang L. H., Cruz-Rojas R. Effects of attributing
serious mental illnesses to genetic causes on orientations to
treatment. Psychiatr Serv 2006; 57: 382–7.
11. Marteau T., Senior V., Humphries S. E., Bobrow M., Cran-
ston T., Crook M. A. et al. Psychological impact of genetic
testing for familial hypercholesterolemia within a previ-
ously aware population: a randomized controlled trial. Am J
Med Genet 2004; 128A: 285–93.
12. Wright A. J., Weinman J., Marteau T. M. The impact of
learning of a genetic predisposition to nicotine dependence:
an analogue study. Tob Control 2003; 12: 227–30.
13. AveyardP.,BrownK.,SaundersC.,AlexanderA.,Johnstone
E., Munafo M. et al. A randomised controlled trial of weekly
versus basic smoking cessation support in primary care.
Thorax 2007; DOI: 10.1136/thx.2006.071837.
14. Velicer W. F., DiClimente C. C., Rossi J., Prochaska J. O.
Relapse situations and self-efﬁcacy: an integrative model.
Addict Behav 1990; 15: 271–83.
15. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom
K.O.Thefagerstromtestfornicotinedependence:arevision
of thefagerstromtolerancequestionnaire.BrJAddict1991;
86: 1119–27.
16. SRNT Sub-Committee on Biochemical Veriﬁcation. Bio-
chemical verﬁcation of tobacco use and cessation. Nicotine
Tob Res 2002; 4: 149–59.
17. MuthenB.O.,MuthenL.K.MplusUser’sGuide.LosAngeles,
CA: Muthen & Muthen; 2006.
Attributing smoking to genes and quitting 1663
© 2007 The Authors. Journal compilation © 2007 Society for the Study of Addiction Addiction, 102, 1657–166418. Staring A. B. P., Breteler M. H. M. Decline in smoking
cessation rate associated with high self-efﬁcacy scores.
Prev Med 2004; 39: 863–8.
19. Segan C. J., Borland R., Greenwood K. M. Do transtheoreti-
cal model measures predict the transition from preparation
to action in smoking cessation? Psychol Health 2002; 17:
417–35.
20. Velicer W. F., Norman G. J., Fava J. L., Prochaska J. O.
Testing 40 predictions from the transtheoretical model.
Addict Behav 1999; 24: 455–69.
21. Carlson LE, Taenzer P, Koopmans J, Casebeer A. Predictive
value of aspects of the Transtheoretical Model on
smokingcessationinacommunity–based,large–groupcog-
nitive behavioral program. Addict Behav 2003; 28: 725–40.
1664 Alison J. Wright et al.
© 2007 The Authors. Journal compilation © 2007 Society for the Study of Addiction Addiction, 102, 1657–1664